Trial for potential coronavirus drug remdesivir running ahead of schedule – New York Post

0
290

Trials to test the efficacy of the Gilead drug remdesivir to treat COVID-19 are running ahead of schedule and could be completed as early as mid-May, says the lead investigator on the project. US-b…
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here